Sponsored content Eye health is something many of us take for granted. But looking after our eyes is important for ...

HealthDay News — Socioeconomic factors are linked to an increased risk for age-related macular degeneration (AMD), according to a study published online July 1 in Health Data Science.

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

This drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related macular degeneration (nAMD ... promising results from the first-in-human ...

You may have seen advertisements claiming to eliminate the need for eyeglasses through vision therapy or vision training – ...

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

The FDA has cleared its first light-based therapy for dry age-related macular degeneration—which the agency described as ...

PulseSight plans to submit a phase I clinical trial authorization (CTA) by the end the year, to be closely followed by a phase II proof-of-concept to demonstrate the efficacy and the safety of its ...

The Eyes Have It is a partnership of Macular Society, Fight for Sight/Vision Foundation ... the vision of someone with increasingly severe levels of age-related macular degeneration. The device ...

Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from age-related macular degeneration, a progressive disease afflicting about 11 ...

Age-related macular degeneration (AMD) causes your central vision to get worse as you get older. An estimated 19.6 million people over 40 live with AMD, and nearly 1.5 million of them have their ...